Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.
Registrars:
Capita Registrars
Key Personnel
Non-Executive Director:
Mark Goldberg, Darlene Deptula-Hicks , Trevor Nichols, Paul Fry
Non-Executive Chairman:
Shaun Chilton
Contact Details
Address:
Unit 20, Ash Way, Thorp Arch Estate, Wetherby, United Kingdom